PART IIIMARKETING ORGANISMS

Applications for renewal of consent to market18

1

Where a consent has been granted under section 111(1) of the Act to market genetically modified organisms which were first marketed in Scotland, any application to renew that consent shall be made in writing to the Scottish Ministers–

a

before 17th October 2006 where the consent was granted before the coming into force date of these Regulations; or

b

no later than nine months before the expiry of the consent in all other cases.

2

The application shall contain–

a

a copy of the consent to market the genetically modified organisms;

b

where the consent to market was granted–

i

after the coming into force date of these Regulations, a report on the results of the monitoring carried out in accordance with the requirements of regulation 28(f); or

ii

before that date, a report on the results of any monitoring carried out on the relevant product;

c

any other new information which has become available with regard to the risks of the product causing damage to the environment; and

d

as appropriate, a proposal for amending, complementing or adding to the conditions of the existing consent, including the conditions concerning future monitoring, and a proposal for the time limitation of the new consent.

3

Any consent to market genetically modified organisms first marketed in Scotland which was granted under section 111(1) of the Act before the coming into force date of these Regulations and for which no application for renewal under paragraph (1) has been received by the Scottish Ministers before 17th October 2006 shall be treated as having expired on that date.

4

Any consent to market genetically modified organisms marketed in Scotland which was granted under section 111(1) of the Act before the coming into force date of these Regulations and for which an application for renewal under paragraph (1) is refused shall be treated as having expired on 17th October 2006 or the date of refusal of the application, whichever is the later.